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ISSObjective: CCL3L andCCL4L genes encodeHIV-suppressive chemokines, colocalize on
chromosome 17q12 and have copy number variation. Copy number variation of CCL3L
associates with HIV-AIDS susceptibility. Here, we determined the influence of the
combinatorial content of distinct CCL3L and CCL4L genes on HIV-AIDS susceptibility.
Methods: By designing gene-specific assays, the association between doses of all CCL3L
orCCL4Lgenesor their individual duplicatedcomponents (CCL3La/bandCCL4La/b)with
HIV-AIDS susceptibility was determined in 298 perinatally exposed Ukrainian children.
Results: The odds of transmissionwas increased in children with less than two copies of
CCL3L or CCL4L, compared with those with at least two copies, and 10-fold higher
when both mother and offspring had less than two CCL3L or CCL4L copies, compared
with mother–child pairs with at least two copies. The extent of the pair-wise corre-
lations between CCL3La, CCL3Lb, CCL4La and CCL4Lb copy number varied exten-
sively, with an inverse correlation between CCL4L genes that transcribe a classical
chemokine (CCL4La) versus aberrantly-spliced transcripts (CCL4Lb). Children posses-
sing only CCL4Lb progressed four times faster to AIDS than those with only CCL4La. A
lower content of CCL3L and CCL4L genes that transcribe classical chemokines was
associated with enhanced HIV-AIDS susceptibility.
Conclusion: Transmission risk is greatest when mother and offspring both have low
CCL3L or CCL4L gene doses. The impact on HIV-AIDS susceptibility of the chemokine
gene-rich locus on 17q12 is dependent on the balance between the doses of genes
conferring protective (CCL3La andCCL4La) versus detrimental (CCL4Lb) effects. Hence,
the combinatorial genomic content of distinct genes within a copy number variable
region may determine disease susceptibility.
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680IntroductionAIDS 2009, Vol 23 No 6The results of the recent STEP trial [1] showing that aHIV-
1 vaccine may have increased the risk of acquiring HIV
prompted a call to define with greater precision the
correlates of protection. A powerful approach to accom-
plish this is to identify host genetic determinants that alter
risk of HIV acquisition and disease progression rates.
Identification of such determinants in children exposed
perinatally to HIV can be especially informative because
approximately 70–90% of such children resist infection,
despite high exposure to virus and absence of antiretroviral
prophylaxis [2]. Here, we investigated such children to
determine the impact on HIV-AIDS susceptibility of
duplicated genomic regions that are enriched for
chemokine genes for whom in-vitro studies [3–10]
implicate a central role for their encoded products in
HIV-AIDS pathogenesis.
Copy numbers of DNA segments [denoted as copy
number variations (CNVs)] are implicated in disease
susceptibility [11–16]. A CNV with relevance to HIV-
AIDS susceptibility is for the segmental duplication that
contains the gene encoding CC chemokine ligand 3-like 1
(CCL3L1). CCL3L1 [macrophage inflammatory protein
1 alpha P (MIP-1aP)], a nonallelic isoform of CCL3
(MIP-1aS), is the most potent agonist of CC chemokine
receptor 5 (CCR5), themajorHIV coreceptor, and among
CCR5 chemokine ligands it exhibits maximal HIV-
suppressive properties [5–8]. Association studies for
the D32 and other polymorphisms in CCR5 [17–23]
established a key role for CCR5 expression in HIV
pathogenesis. By analogy, the genotype–phenotype
associations for the copy number of the CCL3L1-
containing segmental duplication suggest a role for this
structural variation in HIV-AIDS pathogenesis. Prior
studies indicate that a low copy number of CCL3L1 is
associatedwith an increased riskof acquiringHIV infection
[24–28], higher viral loads [24,26,29,30], a faster rate of
decline of CD4þ T-cell counts or progression to AIDS
[24,30,31], impaired recovery of CD4þ T-cell counts [31]
and function [30] during antiretroviral therapy (ART),
lower HIV-specific CD4þ and CD8þ T-cell responses
[29], reduced CCL3 chemokine levels [24,25,32], higher
numbers of HIV target cells (%CD4þ/CCR5þ cells)
[24,33] and reduced cell-mediated immune responses [30].
Extending this concept to nonhuman primates, a low
copy number of CCL3L genes in Asian and Chinese
macaques is associated with an accelerated progression to
experimental AIDS in these animals [34].
However, these previous studies have not accounted for
the full impact on HIV-AIDS susceptibility of CNV of
other chemokine genes that along with CCL3L1 localize
to chromosome 17q12, a hot spot for segmental
duplications [11,12]. These genes include two other
CCL3L (CCL3L2 and CCL3L3) genes and two CCL4L
(MIP-1b-like) genes designated as CCL4L1 andpyright © Lippincott Williams & Wilkins. UnauthorCCL4L2 [3,4,9,10,32]. One possibility was that if the
CNV of all the CCL3L and CCL4L genes reside on a
single segmental duplication, then the associations of
these CNVs with HIV-AIDS susceptibility should be
identical. However, this is unlikely because this genomic
region is replete with many potential breakpoints that
may lead to nonidentical duplicated segments [36].
Underscoring this, although there is a high degree of
correlation between the copy number of CCL3L and
CCL4L genes, individuals contain more copies of
CCL3L than CCL4L [32]. We therefore tested the
hypothesis that the overall phenotypic impact of the
chemokine gene-rich locus at chromosome 17q12 region
on HIV-AIDS susceptibility will be influenced by the
combinatorial content of different CCL3L and CCL4L-
containing segmental duplications. To test this, we
developed specific probes for the distinct CCL3L and
CCL4L genes and determined their associations with
HIV-AIDS susceptibility in a cohort of children exposed
perinatally to HIV-1 from the Ukraine.Methods
Cohort
We studied a cohort of 298 children from Ukraine
who were exposed perinatally to HIV-1 between 1998
and 2006. Of these, 178 (59.7%) were infected. This
distribution is not indicative of the perinatal
transmission rate for HIV-1 infection, as the recruitment
of children was based on HIV status. DNA was also
available from the mothers of 89 children. To minimize
potential confounding due to population stratification,
only children and mothers of Slavic descent, the most
common ethnic group found in Ukraine, were included
in the study. These patients were recruited at the main
outpatient HIV-1 reference centers (‘Municipal Centers
for HIV Management and Prophylaxis’) in the Dnepro-
petrovsk region. All pregnant women within this region
who test positive for HIV are referred to these centers.
Additionally, all HIV-positive children born to these
mothers also receive their medical care in these centers.
Informed written consent was obtained from parents
or legal guardians of all the children, and directly from
the adults. The study was approved by the Institutional
Review Boards of the participating institutions.
The characteristics of the study individuals are given
in Table 1.
Study outcomes
The main outcome measures were HIV serostatus and
progression to AIDS [1993 criteria of the Center for
Disease Control and Prevention (CDC) classification for
children].
Genotyping
Taq Man real-time assays similar to those described
previously [24] and described in the Supplementaryized reproduction of this article is prohibited.
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Table 1. Characteristics of the children included in the study.
Parameter HIV infected HIV uninfected P
Number of children 178 (59.7%) 120 (40.3%) –
Did not receive ZDV prophylaxis 123 (69.1%) 44 (36.7%) 3.2108
Received breastfeeding [n (%)] 17 (9.6%) 5 (4.1%) 0.077
Hemoglobin (g/dl) [mean (SE)] 10.8 (0.09) 11.1 (0.11) 0.030
RBC count [106/ml; mean (SE)] 4.21 (0.08) 4.36 (0.29) 0.264
Baseline CD4þ T-cell count (cells/ml) [mean (SE)] 968.2 (62.2) 2515.8 (11.2.9) <11022
Baseline CD4 percentage [mean (SE)] 22.9 (0.82) 38.8 (0.75) <11022
Average age at initiation of HAART [years, mean (SE)] 5.00 (0.35) – –
Children developing AIDS [n (%)] 56 (31.5%) – –
Total duration of follow-up (person years) 735.33 – –
Duration of follow-up [years, median (IQR)] 7.63 (5.29) – –
ZDV, zidovudine; P, significance value; SE, standard error.Materials and Fig. S1 were used to quantify the CNVof
CCL3L and CCL4L genes. Primer and probe sequences
are listed in Supplementary Table 1.
Statistical analysis
The association between gene copy number and risk of
acquiring HIV infection was assessed by using logistic
regression analyses, and rate of disease progression was
investigated by using Kaplan–Meier survival curves and
Cox proportional hazards modeling. Attributable frac-
tion was estimated as described previously [24]. The
pattern of correlations among the copy numbers of the
different CCL3L and CCL4L genes was determined
using principal components analyses. For this, a factor
solution provided by using a minimum eigenvalue of
one with the results optimized using the varimax
rotation was used. Details of factor analyses are as
described in the Supplementary Material. All statistical
analyses were conducted using the Stata 7.0 (Stata
Corporation, College Station, Texas, USA) software
package.Results
Nomenclature and PCR assay precision
In this study, we denoted CCL3L1 (MIM:601395),
CCL3L2 (MIM:609467), CCL3L3 (MIM:609468),
CCL4L2 (MIM:610757) and CCL4L1 (MIM:603782)
as CCL3La, CCL3Lb, CCL3La, CCL4La and CCL4Lb,
respectively (Fig. 1a and b), for the following reasons. In
prior studies [24–32], because of the nature of the PCR
primer probes used, we and others assessed the copy
number of all CCL3L genes (CCL3L1, CCL3L2,
CCL3L3) and had previously designated this composite
as theCCL3L1-containing segmental duplication (Fig. 1a
and b). CCL3L1 and CCL3L3 are separate genes, each
having three identical exons that encode identical
proteins [3,5], and therefore they are together denoted
here as CCL3La (CCL3L1þCCL3L3¼CCL3La;
Fig. 1a–c). On the basis of current literature, CCL3L2,
designated here as CCL3Lb, is thought to contain onlyopyright © Lippincott Williams & Wilkins. Unauthtwo exons whose sequences are identical to those found
in exons 2 and 3 inCCL3L1 andCCL3L3 [3,5]. Because
CCL3Lb (CCL3L2) lacked the first exon found in
CCL3La (CCL3L1 or CCL3L3), it has been considered
as a pseudogene [3,5]. However, by bioinformatics and
mRNA profiling, we identified novel 50 exons for
CCL3Lb, which give rise to two alternatively spliced
transcripts (CCL3Lb-v1 and CCL3Lb-v2, Fig. 1c and
data not shown). These alternatively transcribed mRNA
species contain chemokine-like domains but are not
predicted to encode classical chemokines (data not
shown). Hence, CCL3La and CCL3Lb transcribe two
distinct kinds of transcripts; the former encoding classical
chemokines and the latter encoding alternatively spliced
transcripts with novel 50 exons (Fig. 1c).
Similarly, CCL4L represents a composite of CCL4Lb
(CCL4L1) and CCL4La (CCL4L2), two distinct genes
that have identical exonic sequences (Fig. 1a and b, [3,5]).
Although these two genes have identical exonic
sequences, a (A!G) transition in the splice acceptor
site in the intron II of CCL4Lb relative to CCL4La leads
to generation of aberrantly spliced CCL4Lb transcripts,
that is, formation of transcripts with retention of portions
of intron II or partial loss of exon 3 (Fig. 1d). Hence,
CCL4La produces transcripts that are predicted to
encode a classical chemokine, whereas CCL4Lb trans-
cribes aberrantly spliced mRNA species (Fig. 1d).
On the basis of the aforementioned, we developed two
separate assays to quantify the total copy number of all
CCL3L or CCL4L genes, and separate assays each for
the individual components of CCL3L (CCL3La and
CCL3Lb) and CCL4L (CCL4La and CCL4Lb). The
PCR assays we developed estimated the copy number of
these individual chemokine gene CNVs with high
precision (Fig. S1). The estimates of the sum of the
copy number of CCL3La and CCL3Lb or CCL4La and
CCL4Lb using these individual PCR assays were very
similar to the estimate of the total copy number of
CCL3L or CCL4L genes, respectively, with 100%
concordance between the estimates for zero, one, two
or at least two copies (data not shown).orized reproduction of this article is prohibited.
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Fig. 1. Chromosome 17q12 segmental duplication, chemokine gene copy number variation nomenclature and correlation
between copy number of CCL3L and CCL4L. (a) Schematic representation of CCL3, CCL4, CCL3L and CCL4L genes. Arrows
indicate the orientation of each gene. Shown on top is the distance between the indicated genes. Map is not to scale. (b)
Nomenclature ofCCL3L andCCL4L genes used here and previously [9,24,26,28,30,31]. (c) and (d) Schematic representation of the
exon–intron structure of (c) CCL3L and (d) CCL4L genes. In (d), the downward pointing arrow indicates the A!G transition that
leads to the generation of aberrantly spliced CCL4Lb transcripts, and the splicing patterns of these mRNA species are indicated by
the curved arrows. Thus, a CCL4L copy, designated here as CCL4La, has the intact AG intron–exon splice sequence and is
predicted to transcribe an intact full-length CCL4L transcript. By contrast, the other CCL4L copy, designated here as CCL4Lb, has a
mutated intron–exon splice site sequence (GG), and this results in the formation of a set of aberrantly spliced transcripts that are
predicted to produce CCL4L proteins that may not function as classical chemokines (as described by Colobran et al. [9]). Boxes
represent exons, which are identified by Arabic numerals and the lines joining the boxes are the introns, which are identified by
Roman numerals. Figure not to scale. (e) Scatter plot showing the correlation of the CCL3L and CCL4L genes copy numbers for all
study individuals. (f) Distribution of CCL3L and CCL4L gene copy number among all study individuals. Grey represents number of
individuals who have the same dose of CCL3L and CCL4L. The numbers below the grey boxes represent the number of individuals
that have more copies of CCL3L than CCL4L.CCL3L–CCL4L dose and HIV-AIDS risk
The distribution of CCL3L copy number in Ukrainian
HIV-positive or HIV-negative children and HIV-positive
mothers were similar to those observed in individuals of
European descent [24], and the average copy number of
CCL3L in this population was two (Fig. S2a). Although
the copy number of CCL3L and CCL4L were highlypyright © Lippincott Williams & Wilkins. Unauthorcorrelated (92%, P< 0.0001), the gene dose of CCL3L
was higher than that forCCL4L (Fig. 1e and f). Given this
high correlation, predictably, the distribution of CCL4L
and CCL3L were very similar (compare Fig. S2a and b),
and therefore associations of the total CCL4L gene dose
with HIV-AIDS susceptibility would be expected to be
similar to those detected for the total CCL3L gene dose.ized reproduction of this article is prohibited.
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Fig. 2. Association of the CCL3L and CCL4L gene copy number with risk of acquiring HIV infection. (a and b) The risk of HIV
acquisition based on the (a) CCL3L and (b) CCL4L copy number in children. Left panel shows the distribution of CCL3L or CCL4L
copy number categorized as less than two or at least two in the HIV-positive and HIV-negative children. Right panel shows results
of logistic regression analyses unadjusted (shown in green) and adjusted (shown in red) for receipt of ZDV prophylaxis. The
diamonds and error bars represent the OR and 95% CI, respectively. (c) Association of CCL3L copy number in the mother–child
pairs with the risk of vertical transmission. The data on the left shows the distribution of the 89 mother–child pairs by gene copy
number and the bar chart shows the proportion of children within each of the four categories who acquired HIV infection. The risk
of HIV acquisition was estimated using multinomial logistic regression analysis which was unadjusted (left) and adjusted (right) for
receipt of ZDV prophylaxis. ZDV, zidovudine; CI, confidence interval; OR, odds ratio; P, significance value.In a previous study [24], we found that in European–
Americans or Argentinean children, possession of a
copy number of CCL3L that was less than the average
found in the overall population (two) was associated
with an increased risk of acquiring HIV infection.
Concordantly, among Ukrainian children exposed
perinatally to HIV, possession of a copy number of
CCL3L or CCL4L that was less than two was associated
with a trend for a nearly 75% increased risk of
acquiring HIV before or after accounting for receipt of
zidovudine (ZDV) prophylaxis, respectively, compared
with children who had at least two copies of CCL3L or
CCL4L (Fig. 2a and b).
We next determined whether risk of transmission differed
based on whether a mother and her offspring had similar
or dissimilar doses of CCL3L. Compared with mother–
child pairs in which both the mother and her offspring
had at least two CCL3L copies, the risk of transmission
was significantly higher by a factor of approximately 10–
13 only when both the mother and her offspring had a
CCL3L gene dose of less than two (Fig. 2c). In these 89opyright © Lippincott Williams & Wilkins. Unauthmother–child pairs, identical associations were detected
for the copy number of CCL4L. HIV-positive children
with less than two CCL3L or CCL4L copies had
experienced an approximately two times faster rate of
progression to AIDS than those with a higher gene dose
(Fig. 3a and b).
Relationships among CCL3L and CCL4L genes
We next investigated the phenotypic impact of the
different components of CCL3L and CCL4L genes.
Figure S2 (c) and (d) show the distribution of the copy
numbers of the different CCL3L and CCL4L genes in
the study individuals. The distribution patterns of
CCL3La and CCL4La were very similar to those
of the total copy numbers of CCL3L and CCL4L,
respectively, whereas most study individuals lacked
CCL3Lb and CCL4Lb (Fig. S2).
The pair-wise comparisons of the copy number of
the different CCL3L and CCL4L genes revealed
the following pattern. There was a highly statistically
significant positive correlation between the copy numbersorized reproduction of this article is prohibited.
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inverse correlation. (d) Kaplan–Meier plots of subgroups based on CCL4La and CCL4Lb copy number and their effects on disease
progression in infected children (n¼147). Zero (0) indicates that the gene is not present, 1 indicates the presence of one copy
number of CCL4La or CCL4Lb. The red-colored Kaplan–Meier plot is for individuals who lack CCL4La, but have one or more
copies of CCL4Lb; the green Kaplan–Meier plot is for individuals who have one copy each of CCL4La and CCL4Lb; and the
blue Kaplan–Meier plot is for those who lack CCL4Lb and have one or more copies of CCL4La. The latter group represents
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RH, relative hazard.of CCL3La and CCL3Lb, CCL3La and CCL4La,
CCL3La and CCL4Lb, CCL3Lb and CCL4La
(Fig. 3c). In contrast, there was a highly statistically
significant negative correlation between the copy number
ofCCL4La andCCL4Lb (r¼0.30,P< 0.0001; Fig. 3c).
On the basis of the observed inverse relationship between
CCL4La andCCL4Lb (Fig. 3c) and becauseCCL4La but
not CCL4Lb-derived transcripts are predicted to encode
a classical chemokine (Fig. 1d), we surmised the
following: those who had more ‘functional’ chemo-
kine-encoding CCL4La copies than CCL4Lb copies
might fare better in terms of their disease course than
those who only possessed CCL4Lb copies. To test this
possibility, we stratified HIV-infected children into threepyright © Lippincott Williams & Wilkins. Unauthorgroups as shown in Fig. 3d. Consistent with our
hypothesis, possession of only CCL4Lb was associated
with a four-fold faster rate of disease progression than
those who only possessedCCL4La (compare blue and red
Kaplan–Meier plots, Fig. 3d). By contrast, those who had
one copy of CCL4La and CCL4Lb displayed an
intermediate disease phenotype (green Kaplan–Meier
plot, Fig. 3d). The Kaplan–Meier plot of individuals who
had higher copy numbers of CCL4La than CCL4Lb was
similar to those who only possessed CCL4La (data not
shown). These findings underscored the beneficial and
negative associations of CCL4La and CCL4Lb copies on
HIV disease course, respectively. There were too few
individuals who were null for CCL3La to conduct
similar analyses.ized reproduction of this article is prohibited.
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CCL4Lb, which transcribes aberrantly spliced mRNA species. (b) Distribution of the factor 1/factor 2 (f1/f2) score ratio in study
groups. HIV-positive children as well as their mothers had a significantly lower f1/f2 score ratio as comparedwith the HIV-negative
children as assessed by Mann–Whitney test. For these analyses, we took the ratio of the scores for the first and second factors for a
given study individual. As the factor scores were scattered over the interval (2.21 and 4.27), we linearly transformed the raw
factor scores by adding a constant of 2.5. This transformation converted all the factor scores into positive real numbers without
affecting the original distribution of the factor scores. We then took the ratio of these positive factor scores. (c) Association of the
log-transformed f1/f2 ratio with the risk of acquiring HIV (analyzed using logistic regression) and rate of disease progression
(analyzed using Cox proportional hazards regression). The diamonds and error bars represent the point estimates and 95% CIs for
OR (for risk of HIV acquisition) and relative hazards (for rate of disease progression). Results are from unadjusted and adjusted (for
the receipt of prophylaxis) regression models. The numbers at the bottom show the significance values. CI, confidence interval;
OR, odds ratio.CCL3L–CCL4L components and HIV-AIDS
susceptibility
The importance of accounting for the complexity
imposed by the combinatorial gene content generated
by variable CNV on the 17q12 was underscored by the
observation that there was a positive correlation between
the frequencies of each of the CCL3L and CCL4L genes
except for the pair-wise comparison of CCL4La and
CCL4Lb (Fig. 3c) and the contrasting disease-influencing
effects associated with these two genes (Fig. 3d). This
raised the possibility that the relative balance between the
content of ‘protective’ versus ‘detrimental’ duplicated
chemokine genes influences the HIV-AIDS-influencing
phenotypic effect of the chemokine gene-rich 17q12
regions that have undergone segmental duplications. We
used principal components analyses to address this
possibility as well as to gain a greater understanding of
the observed pattern of correlations between the
chemokine gene copy numbers.
By factor analyses, we found that these four components
loaded differentially onto a two-factor solution (Fig. 4a):
CCL3La andCCL4La loaded heavily onto the first factor
(factor 1), whereas the second factor (factor 2) was
represented by CCL4Lb loading very highly onto it. Of
note, CCL3Lb loaded almost equivocally on both theopyright © Lippincott Williams & Wilkins. Unauthfactors suggesting that this is a distinct component. The
degree of uniqueness of CCL3La, CCL3Lb, CCL4La
and CCL4Lb was 0.05, 0.59, 0.04 and 0.11, further
emphasizing that with regards to the copy number
distribution, the copy number of CCL3Lb was uniquely
different from the distribution of CCL3La, CCL4La and
CCL4Lb. Thus, factor 1 largely reflects CCL3La and
CCL4La, whereas factor 2 largely reflects CCL4Lb.
To assess whether biological interpretations made from
the correlation patterns and principal components analyses
were justifiable, we conducted the following analyses.
Using the results from principal components analyses, we
generated standardized scores for the first and second factor
for each individual. On the basis of this, we surmised that a
lower score for factor 1, which equates with a lower
number of CCL3La and CCL4La copies would more
likely associate with an HIV-positive status. Consistent
with this,weobserved that themedian for the factor 1 score
(in parenthesis) in HIV-negative children (0.25) was
significantly higher than that found in HIV-positive
children (0.13; P¼ 0.042 for comparison) and HIV-
positive mothers (0.43, P¼ 0.0067 for comparison).
These observations suggested that a reduction in the
overall gene content of CCL3La and CCL4La confers a
differential risk of acquiring HIV.orized reproduction of this article is prohibited.
Co
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two factors in a given individual was a determinant of the
risk of acquiring HIV infection and progressing to AIDS.
A ratio of the factors 1 (f1) and 2 (f2) scores (referred to
here as f1/f2 score ratio) exceeding one indicates a relative
enrichment of the first factor, whereas a value less than
one indicates a relative enrichment of the second factor.
We found that HIV-uninfected children had significantly
higher values of the f1/f2 ratio compared with HIV-
infected children and HIV-infected mothers (Fig. 4b).
Using logistic regression analysis, we then determined if
the risk of HIVacquisition is influenced by the f1/f2 score
ratio. We found that each log-fold increase in the f1/f2
score ratio was associated with approximately 43 and 41%
reduced likelihood of acquiring HIV before and after
accounting for ZDV prophylaxis, respectively (Fig. 4c).
Similarly and to a comparable extent, we found by using
Cox proportional hazards regression analyses that a log-
fold increase in the f1/f2 score ratiowas associated with an
approximately 38 and 37% decreased rate of progression
to AIDS in the HIV-infected children before and after
accounting for the receipt of prophylaxis, respectively
(Fig. 4c).Discussion
The present study has two major findings. First, they
confirm and amplify the results of previous studies which
showed that a low dose of CCL3L genes (referred
previously as the CCL3L1-contianing segmental dupli-
cation) is associated with an increased risk of acquiring
HIV and progressing rapidly to AIDS. Furthermore, our
results demonstrate that a low CCL4L gene dose has
similar associations. These results add credence to the
notion that these genetic determinants may influence
epidemic spread of HIV. Successful transmission of HIV-1
depends on both the infectiousness of the HIV-positive
individual and susceptibility of the HIV-negative indi-
vidual. Infectiousness is in part dependent on the viral
load [37,38], and previous studies [24,26,29–31] indicate
that a low copy number of CCL3L is associated with a
progressive HIV disease course and higher viral load.
Thus, it follows that mother–child dyads in which both
members have a low copy number ofCCL3L should have
the highest probability of transmission, which is what we
observed in this study. In 12.4% of mother–child pairs,
both the mother and the child possessed less than two
CCL3L (or CCL4L) copies and 91% of these children
had acquired HIV infection. This translated to an odds
ratio of more than 10 for the risk of transmission, which is
among the highest odds for transmission that we have
observed, and an attributable fraction of 18.4% (95%
confidence interval 6.1–30.6%). These results suggest
that a substantial proportion of vertical transmission in our
study individuals may be explained by mother–child
dyads in which each member has a low CCL3L/CCL4Lpyright © Lippincott Williams & Wilkins. Unauthordose. By analogy, we hypothesize that a similarly high
proportion of transmission may occur among HIV-
positive/HIV-negative sexual partner pairs when each
member has a low CCL3L dose, a premise that is also
supported by our modeling studies [39]. As there was
complete concordance in the gene copy numbers of
CCL3L and CCL4L in the mother–child pairs in which
both mother and offspring had less than two CCL3L
copies, these data also reflect the effects of the overall
CCL4L gene copy number on transmission.
Second, our findings illustrate a chromosomal region
whose genomic architecture is highly complex such that
individuals do not inherit the same complement of
CCL3L and CCL4L genes. However, we suggest that
uncovering this complexity might be necessary to define
the true phenotypic impact of these duplicated genes on
HIV-AIDS susceptibility. This is exemplified by the
finding that the copy numbers of CCL4La and CCL4Lb
are inversely correlated and have opposing effects on
AIDS progression rates, despite the fact that sequences of
the coding exons of these two genes are identical [3,5].
Furthermore, we show that the balance between the copy
numbers of the genes that transcribe classical versus
aberrantly spliced CCL3L and CCL4L mRNA species
influences HIV-AIDS susceptibility; a higher gene
content of CCL4Lb (CCL4L1) or a lower content of
CCL3La and CCL4La increased the risk of transmission
and an accelerated disease course. Underscoring the
negative influence of CCL4Lb on HIV acquisition, a
previous study [9] also found that HIV-positive individ-
uals were enriched for more copies of this gene compared
with HIV-negative controls.
It is conceivable that there are additional tiers of genetic
and mRNA complexity in this locus. We have identified
novel 50 exons for CCL3Lb, a gene that was previously
thought to only have two exons, which are homo-
logous to exons 2 and 3 ofCCL3L1 orCCL3L3; for this
reason,CCL3Lbwas considered as a pseudogene [5]. We
found that these novel 50 exons give rise to two
alternatively (CCL3Lb-v1 and CCL3Lb-v2) spliced
transcripts. These transcripts contain chemokine-like
domains, but are not predicted to encode classical
chemokines, and additional studies will be required to
uncover the functional properties of these CCL3L
mRNA species.
The present findings have four implications. First,
although CCL4La and CCL4Lb share 100% sequence
identity in their coding sequences, the findings presented
herein and those from our preliminary studies in other
populations indicate that the pair-wise correlations
among and between CCL3L and CCL4L genes, and
the degree of the inverse correlation between the copy
number of CCL4La and CCL4Lb genes may vary
between populations. This suggests that genotype–
phenotype association studies may need to account forized reproduction of this article is prohibited.
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of this locus.
The second implication of our results is that the
assessment of CCL4L dose is capturing the sum of two
genes (CCL4La and CCL4Lb) whose copy number
frequencies are inversely related and who have opposing
effects on HIV disease course. Thus, the true phenotypic
impact of CCL4La and CCL4Lb cannot be made using
CCL3L copy number as a proxy for CCL4L or by
evaluation of the composite CCL4L. This might explain
in part why previous studies may not have found an
association between CCL4L copy number and HIV
disease [40]. Third, the CCL3Lb copy number loaded
weakly and equivocally on factor 1 or 2, indicating that
this gene may influence HIV-AIDS pathogenesis by as yet
unidentified means. Consistent with this possibility, we
have found that CCL3Lb (CCL3L2) generates alter-
natively transcribed transcripts whose 50 exons differ from
those of CCL3La (CCL3L1 and CCL3L3) (Fig. 1c).
Fourth, greater insights into the immune correlates linked
to a high gene dose of specific CCL3L and CCL4L
chemokine genes that confer protective effects may
provide novel insights into the correlates of protection.
The importance of elucidating these correlates is also
highlighted by the recent observation that CCL3L copy
number may influence susceptibility to Simian-AIDS in
rhesus macaques [34,41].
In summary, we confirm and extend significantly prior
results indicating that a low copy number of CCL3L
influences risk of HIVacquisition and disease progression
in a cohort of children exposed perinatally to HIV. We
demonstrate a role for CCL4L CNV in HIV-AIDS
susceptibility. However, we show that dissecting the
combinatorial genomic complexity posed by varying
proportions of distinctCCL3L andCCL4L genes among
individuals is required to elucidate the complete
phenotypic impact of this locus in HIV, and suggest that
the balance between the copy number of the different
CCL3L and CCL4L genes influences HIV-AIDS
susceptibility. From a broader perspective of relevance
to the CNV field, it might be important to determine
whether the combinatorial genomic content generated
by distinct genes within a copy number variable region
determines disease susceptibility.Acknowledgements
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CCCL3L and CCL4L in HIV-AIDS pathogenesis Shostakovich-Koretskaya et al. 689Genotyping methodsNomenclature of CCL3L and CCL4L chemokine genes
is as illustrated and described in the main text (Fig. 1a,b).
DNA was isolated from EDTA-treated whole blood by
using a Qiagen kit. The copy number of CCL3L
(previously designated as the CCL3L1-containing seg-
mental duplication and includes CCL3L1/2/3) was
genotyped as described previously [1]. Similar Taqman
based Real-time PCR assays were developed to genotype
the copy number of the other chemokine genes. Briefly,
the human housekeeping beta-globin (BGB) gene was used
as an internal control as a genewith two copies per diploid
genome (pdg). The A431 cell line was used as a standard
for CCL3La, CCL4L and CCL4La with each gene
possessing two copies pdg ([2] and data not shown). The
K562 cell line was used as a standard for CCL3Lb and
CCL4Lb with one and two copies pdg, respectively (data
not shown). CCL4La and CCL4Lb were run in a duplex
assay whereas the others were run in single-plex. Each
sample was run in triplicate in three separate 384-well
plates. Rounded average numbers were used for analysis
and quality control procedure was applied as described
previously [1]. Primer and probe sequences are listed in
the table below.Statistical methods
In this study, we examined the association of the overall
CCL3L and CCL4L gene copy number and their
components (CCL3L1a, CCL3L1b, CCL4La, and
CCL4Lb) with two end-points: risk of HIV acquisition
and rate of progression to AIDS. To summarize the
correlation patterns across the components of theCCL3L
and CCL4L genes we conducted factor analysis using the
method of principal components. For this, we first
extracted significant factors (defined as factors with an
eigenvalue exceeding unity) and then applying a varimax
rotation to the extracted orthogonal factors. In the next
step, we generated factor scores for each extracted factor
for each individual based on the results obtained from the
previous step. We then determined the association of
these factor scores with risk of infection and rate of
progression. Greater details of the method of factor
analysis are discussed below.
Factor analysis
Factor analysis provides an unbiased exploratory means to
understand complex correlation patterns among several
variables and to distill these complex patterns into a
parsimonious mathematical solution called as factors.
Highly correlated variables load onto a common factor
and highly uncorrelated variables segregate onto different
factors. We used a method of principal components to
parse out the complex correlation pattern among the
components of the duplicated genes on chromosomeopyright © Lippincott Williams & Wilkins. Unauth17q12, i.e., CCL3La, CCL3Lb, CCL4La and CCL4Lb
(shown in Fig. 4a). For deriving the factor solution we
used a criterion of a minimum eigenvalue of 1.
Using this criterion we arrived at the following factor
solution:
These results show that there were only two retained
factors based on the four variables (genes) – in other
words the correlation pattern of the components of the
duplicated segment could be summarized using two
factors. Since principal components analysis assumes that
the factors are orthogonal (i.e., the factors are themselves
uncorrelated), we next used the varimax rotation to arrive
at an optimized factor solution as follows:
These results are depicted in Fig. 4a and suggest that the
CCL3La and the CCL4La gene copy numbers loaded
heavily on the first factor while the CCL4Lb gene copy
number loaded onto the second factor. The CCL4La
gene copy number also strongly negatively loaded onto
the second factor. Interestingly, the CCL3Lb gene copy
number loaded equivocally and moderately onto both
the factors.
In the table of results from rotated factor loadings (see
above), the uniqueness of each variable is a measure of theorized reproduction of this article is prohibited.
Copyright © Lippincott Williams & Wilkins. Unauthor
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Fig. S1. Distribution of copy number of the CCL3L and
CCL4L gene components, i.e., CCL3La, CCL3Lb, CCL4La
and CCL4Lb among study subjects. Each dot represents the
copy number of the indicated gene in the study subjects.
Individual subjects are distributed along the abscissa, while
the persons estimated copy number of the indicated genes is
depicted along the ordinate. Note, the copy number for each
individual cluster around the integers (e.g., 0, 1, 2 etc),
demonstrating the precision of the PCR assay.
Fig. S2. Distribution of the CCL3L and CCL4L gene copy number a
copy number among the indicated study subjects. (c-d) Distribution
CCL4L (d) genes in the indicated study groups.degree of correlation of the indicated gene copy numbers
with the factors that were mathematically extracted. It can
be seen that the uniqueness of CCL3La, CCL4La and
CCL4Lb is low indicating that these gene copy numbers
are strongly correlated with the two factors. However, the
CCL3Lb is highly unique and only minimally loads onto
either factor. Therefore, it can be surmised that the
CCL3Lb gene copy number provides unique information
that is distinct from that provided by the other three
variables.
In the next step, to translate the results of factor analysis
into clinically and genetically meaningful information,
we generated factor scores for each individual. In theory,
since the variables load onto factors it is possible to
estimate the degree to which an individual might load
onto that factor given that individual’s data on the
contributing variables. For example, let us assume that the
standardized (z-value/score) results of the Taqman PCR
assays for the four components were 1.5, 0.04, 1.2, and
0.5 for CCL3La, CCL3Lb, CCL4La, and CCL4Lb,
respectively, then that individual’s score for the first factor
will be (based on the coefficients shown in the table
above): (0.89 1.5)þ (0.44 0.04)þ (0.94 1.2)þ
(0.030.5)¼ 2.50. The same individual’s score on
the second factor will be (0.39 1.5)þ (0.47 0.04)ized reproduction of this article is prohibited.
mong study subjects. Distribution of (a) CCL3L and (b) CCL4L
of the copy numbers of each component of the CCL3L (c) and
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Supplementary Table 1. Primers and probes used for assays to quantify the gene copy number of CCL3L and CCL4L genes.CCL3Lwas quantified
as described previously [1].
Gene Primers/Probes Oligonucleotide sequences
CCL3La Sense primer 50-GGGTATGACTTCTTGAACCGACAAA-30
Antisense primer 50-GGTTCTCTGTTTCTCTATGTGATCCA-30
Probe 6FAM-CATGAAGAGAGCTAAGAGAAC-MGBNFQ
CCL3Lb Sense primer 50-CATCCACTCGCTCACACCTGTA-30
Antisense primer 50-GCGGTCGGCGTGTCA-30
Probe 6FAM-AGAGTTGGGCTTATTCT-MGBNFQ
CCL4L Sense primer 50-CATGGTCAGGCAGAGGAAGATG-30
Antisense primer 50-GCTTGCCTCTTTTGGTTTGGAAT-30
Probe 6FAM-TACCACAGGCAAGGGAT-MGBNFQ
CCL4La and CCL4Lb Sense primer 50-GGAAGATGCCTACCACAGGC-30
Antisense primer 50-GCGCAGACTTGCTTGCC-30
CCL4La Probe VIC-CTTGTTCTACaGATTCC-MGBNFQa
CCL4Lb Probe 6FAM-CTTGTTCTACgGATTCC-MGBNFQ a
BGBb Sense primer 50-TCGCTTTCTTGCTGTCCAATTTCTA-30
Antisense primer 50-ATGCTCAAGGCCCTTCATAATATCC-30
Probe VIC-CCTAAGTCCAACTACTAAACTG-MGBNFQ
VIC and FAM, probe reporter fluorescent dyes. MGBNFQ, Molecular-Groove Binding Non-fluorescence Quencher hybridization probes which
allow for using probes at lower melting temperature.
aProbe sequences in lower case represent difference between CCL4La and CCL4Lb.
bBGB, Human housekeeping beta-globin (BGB) gene.þ (0.26 1.2)þ (0.940.5)¼0.18. Thus, this
individual will have a high score for the first factor and
a negative score for the second factor.
Having generated the scores for each individual, we
proceeded to study the association of the factor scores we
created a composite factor score ratio by taking the ratio
of the first factor score and second factor score.
Conceptually, this ratio represents the expansion or
shrinkage of the first factor score relative to the second
factor score. However since both the factor scores can be
distributed over the 2-dimensional real number space, we
first converted these scores into a positive number by
addition of a constant of 2.5.We then took the ratio of the
positive factor scores as an indicator of the relative factor
scores (factor 1/factor 2).opyright © Lippincott Williams & Wilkins. UnauthCharacterization of novel exon
1-containing transcripts encoded by
CCL3Lb (CCL3L2) gene
By using a variety of bioinformatics and molecular
approaches, we generated enough data to support the fact
that the described alternative spliced isoforms in Fig. 1c are
expressed and contain the notated sequences as depicted in
the Fig. 1c. Details about the sequences, methods and
analysis can be obtained from ahujas@uthscsa.edu.References
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